Get started
iSpecimen Inc.iSpecimen Inc.iSpecimen Inc.

iSpecimen Inc.

No trades
See on Supercharts
Overview
Financials News Ideas Discussions Technicals Seasonals

ISPC chart


Full chart

ISPC upcoming earnings


Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats


Market capitalization
‪1.22 M‬ USD
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
−18.93 USD
Net income (FY)
‪−11.10 M‬ USD
Revenue (FY)
‪9.93 M‬ USD
Shares float
‪823.18 K‬
Beta (1Y)
0.47

Employees


Employees (FY)
53
Change (1Y)
−22 −29.33%
Revenue / Employee (1Y)
‪187.32 K‬ USD
Net income / Employee (1Y)
‪−209.42 K‬ USD

About iSpecimen Inc.


Sector
Commercial Services
Industry
Miscellaneous Commercial Services
CEO
Robert Bradley Lim
Website
ispecimen.com
Headquarters
Woburn
Founded
2009
FIGI
BBG00734QDL2
iSpecimen, Inc. is a healthcare organization that engages in procurement of human biospecimen. It collects biofluids, human tissue, hematopoietic stem, and immune cells. The company was founded by Christopher Ianelli in 2009 and is headquartered in Woburn, MA.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—

ISPC news



Ideas



See all ideas 

Technicals


Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

Check out other big names from the same industry as ISPC.

Frequently Asked Questions


The current price of ISPC is 1.13 USD — it has decreased by −11.81% in the past 24 hours. Watch iSpecimen Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange iSpecimen Inc. stocks are traded under the ticker ISPC.
ISPC stock has fallen by −12.50% compared to the previous week, the month change is a −27.74% fall, over the last year iSpecimen Inc. has showed a −76.94% decrease.
ISPC reached its all-time high on Nov 29, 2021 with the price of 579.60 USD, and its all-time low was 1.09 USD and was reached on Mar 28, 2025. View more price dynamics on ISPC chart.
See other stocks reaching their highest and lowest prices.
ISPC stock is 13.39% volatile and has beta coefficient of 0.47. Track iSpecimen Inc. stock price on the chart and check out the list of the most volatile stocks — is iSpecimen Inc. there?
Today iSpecimen Inc. has the market capitalization of ‪1.09 M‬, it has decreased by −13.87% over the last week.
Yes, you can track iSpecimen Inc. financials in yearly and quarterly reports right on TradingView.
iSpecimen Inc. is going to release the next earnings report on May 13, 2025. Keep track of upcoming events with our Earnings Calendar.
ISPC earnings for the last quarter are −2.10 USD per share, whereas the estimation was −3.80 USD resulting in a 44.74% surprise. The estimated earnings for the next quarter are −4.00 USD per share. See more details about iSpecimen Inc. earnings.
iSpecimen Inc. revenue for the last quarter amounts to ‪2.66 M‬ USD, despite the estimated figure of ‪2.95 M‬ USD. In the next quarter, revenue is expected to reach ‪2.98 M‬ USD.
ISPC net income for the last quarter is ‪−1.44 M‬ USD, while the quarter before that showed ‪−2.11 M‬ USD of net income which accounts for 31.73% change. Track more iSpecimen Inc. financial stats to get the full picture.
No, ISPC doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Apr 4, 2025, the company has 53 employees. See our rating of the largest employees — is iSpecimen Inc. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. iSpecimen Inc. EBITDA is ‪−7.48 M‬ USD, and current EBITDA margin is −91.70%. See more stats in iSpecimen Inc. financial statements.
Like other stocks, ISPC shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade iSpecimen Inc. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So iSpecimen Inc. technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating iSpecimen Inc. stock shows the sell signal. See more of iSpecimen Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.